Overexpression of LRG1 dramatically restored tumor growth after U0126/MMA cotreatment, which suggested that synergistic downregulation of LRG1 mediated the antitumor effect of combination treatment (Figure S9D, Supporting Information). The gene discussed is LRG1; the disease is neoplasm.